Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00510744 · ClinicalTrials.gov registry record · NA

Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients

A NA study of Obesity, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT00510744 is a NA study of Obesity that has completed, run by University of Pittsburgh. The registered enrollment target is 5 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00510744, a NA study of Obesity, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Hypothesis: Bypass of the upper GI tract with bariatric surgery results in suppression of pancreatic function resulting in maldigestion and further malabsorption. In this study we will measure pancreatic secretion in previously obese gastric bypass patients with excessive weight loss. If malabsorption is associated with diminished pancreatic secretion, we will test over a 3 month period whether supplementation with enzyme supplements prevent further weight loss.

Conditions Studied

Interventions

  • DRUG pancreatic enzyme supplement

Study Locations (1)

Pennsylvania

  • University of Pittsburgh GCRC - Pittsburgh

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2007-08
Est. Completion 2015-08
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00510744

The ClinicalTrials.gov registry entry for NCT00510744 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which pancreatic enzyme supplement is the first listed.

NCT00510744 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00510744 about?

NCT00510744 is a clinical study titled "Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients". Hypothesis: Bypass of the upper GI tract with bariatric surgery results in suppression of pancreatic function resulting in maldigestion and further malabsorption. In this study we will measure pancreatic secretion in previously obese gastric bypass patients with excessive weight loss. If malabsorpti...

What is the current status of trial NCT00510744?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2007-08. Estimated completion is 2015-08.

What conditions does trial NCT00510744 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00510744?

The interventions under investigation include: pancreatic enzyme supplement (DRUG).

Who is sponsoring clinical trial NCT00510744?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00510744 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.